Advanced Registry Search Results

Search Criteria
  1. Lobbyist name (consultant or in-house lobbyist): LANDAU, DR. CRAIG OR;
  2. Senior Officer name: LANDAU, DR. CRAIG
Start over
Modify criteria
Refine By
Document Type Registrations Status Activity Type Subject Matter of the Lobbying Activity Ministries/Provincial Entities

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Advanced Registry Search Results

Results: 1-6 of 6
  1. Purdue Pharma (Canada)
    Activity type: Organization
    Senior Officer: Dr. Craig Landau
    Registration: 3 of 17 (2013-07-25 to 2014-02-27)
    Posted: 2013-07-29
    Subject matter details: 1
    Lobbying target types: 3
    Government funding: No
    Employees who lobby: 4
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
  2. Purdue Pharma (Canada)
    Activity type: Organization
    Senior Officer: Dr. Craig Landau
    Registration: 8 of 17 (2016-03-29 to 2016-09-25)
    Posted: 2016-04-04
    Subject matter details: 1
    Lobbying target types: 3
    Government funding: No
    Employees who lobby: 5
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
  3. Purdue Pharma (Canada)
    Activity type: Organization
    Senior Officer: Dr. Craig Landau
    Registration: 7 of 17 (2015-09-29 to 2016-03-27)
    Posted: 2015-09-29
    Subject matter details: 1
    Lobbying target types: 3
    Government funding: No
    Employees who lobby: 5
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
  4. Purdue Pharma (Canada)
    Activity type: Organization
    Senior Officer: Dr. Craig Landau
    Registration: 6 of 17 (2015-04-01 to 2015-09-28)
    Posted: 2015-04-13
    Subject matter details: 1
    Lobbying target types: 3
    Government funding: No
    Employees who lobby: 2
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
  5. Purdue Pharma (Canada)
    Activity type: Organization
    Senior Officer: Dr. Craig Landau
    Registration: 5 of 17 (2014-10-01 to 2015-03-30)
    Posted: 2014-10-07
    Subject matter details: 1
    Lobbying target types: 1
    Government funding: No
    Employees who lobby: 6
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
  6. Purdue Pharma (Canada)
    Activity type: Organization
    Senior Officer: Dr. Craig Landau
    Registration: 4 of 17 (2014-03-04 to 2014-08-31)
    Posted: 2014-03-04
    Subject matter details: 1
    Lobbying target types: 2
    Government funding: No
    Employees who lobby: 2
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
Date Modified: